摘要
冠心病的治疗包括三个层面:血管重建治疗解决局部狭窄;改善生活方式是基础;全面合理的药物治疗是核心。而β受体阻滞剂又是重要的一线治疗药物,不仅能降低动脉粥样硬化及急性冠脉综合征的发生发展,还能有效预防、缓解心绞痛发生,改善梗死后左室重构和心功能;降低心肌再梗死率,降低心性猝死和病死率。临床上应用β受体阻滞剂的时机和剂量非常重要。
The treatments of coronary artery disease include 3 levels. ： revascularization of coronary artery, life style treatment and comprehensive drug therapy. Among them β-Receipt Blocker is very important drug in first line treatment . It does not only decrease the development of coronary atherosclerosis and acute coronary syndrome; but could prevent and release angina pectoris; improve left ventricular function, reduce the rate of myocardium reinfarction; reduce the sudden death and mortality. It is very important to take good chance and have right dose for β- Receipt Blocker.
出处
《医学与哲学（B）》
2009年第7期12-13,共2页
Medicine & Philosophy(B)
关键词
冠心病
药物治疗
Β受体阻滞剂
coronary artery disease, drug therapy,β- Receipt Blocker
